PRESYNAPTIC-M2-MUSCARINIC RECEPTORS ON NORADRENERGIC NERVE-ENDINGS AND ENDOTHELIUM-DERIVED M3 RECEPTORS IN CAT CEREBRAL-ARTERIES

被引:25
作者
ALONSO, MJ
ARRIBAS, S
MARIN, J
BALFAGON, G
SALAICES, M
机构
[1] UNIV AUTONOMA MADRID,FAC MED,DEPT FARMACOL & TERAPEUT,C ARZOBISPO MORCILLO 4,E-28029 MADRID,SPAIN
[2] UNIV AUTONOMA MADRID,FAC MED,DEPT FISIOL,MADRID 34,SPAIN
关键词
CAT CEREBRAL ARTERY; PRESYNAPTIC MUSCARINIC RECEPTOR; ENDOTHELIAL MUSCARINIC RECEPTOR; ATROPINE; PIRENZEPINE; AF-DX-116; 4-DAMP;
D O I
10.1016/0006-8993(91)91438-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The muscarinic (M) receptors involved in the vasodilation elicited by acetylcholine (ACh) and in the carbachol inhibition in electrically induced [H-3]noradrenaline (NA) release in cat cerebral arteries was investigated. For this, atropine, pirenzepine, AF-DX 116, 4-DAMP, non-specific, M1, M2 and M3 receptor antagonists, respectively, were used. ACh elicited concentration-dependent relaxations up to 10(-6) M, which were attenuated by these antagonists; the order of potency (pA2 values) to inhibit the ACh-induced relaxation was: atropine (10.1) > 4-DAMP (8.9) > pirenzepine (7.6) > AF-DX 116 (5.9). The electrical stimulation (200 mA, 0.3 ms, 2 Hz, during 1 min) of these arteries preincubated with [H-3]NA caused tritium release which was inhibited by carbachol (10(-6) M). The 4 antagonists attenuated the action of the M agonist; the order of potency (pIC50 values) was: atropine (8.7) > 4-DAMP (8.1) > AF-DX 116 (7.9) > pirenzepine (5.8). The action of McN-A-343, a putative M1 agonist, was also investigated. This agent produced small vasodilator responses and elevated concentrations (5 x 10(-5) M) inhibited the stimulated NA release, which was partially antagonized by atropine (10(-7) M) and pirenzepine (10(-8) and 10(-7) M). These results suggest the existence of M3 and M2 receptors mediating the relaxation induced by ACh and the NA release inhibition evoked by carbachol, respectively.
引用
收藏
页码:76 / 82
页数:7
相关论文
共 46 条
[1]   CEREBRAL BLOOD-FLOW AND VASCULAR REACTIVITY AFTER REMOVAL OF SUPERIOR CERVICAL SYMPATHETIC-GANGLION IN GOAT [J].
ALBORCH, E ;
GOMEZ, B ;
DIEGUEZ, G ;
MARIN, J ;
LLUCH, S .
CIRCULATION RESEARCH, 1977, 41 (03) :278-282
[2]   SOME QUANTITATIVE USES OF DRUG ANTAGONISTS [J].
ARUNLAKSHANA, O ;
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01) :48-58
[3]   A FURTHER SEARCH FOR SELECTIVE ANTAGONISTS AT M2-MUSCARINIC RECEPTORS [J].
BARLOW, RB ;
SHEPHERD, MK .
BRITISH JOURNAL OF PHARMACOLOGY, 1986, 89 (04) :837-843
[4]  
BATINK H D, 1987, British Journal of Pharmacology, V90, p81P
[5]   SYMPATHETIC CONTROL OF CEREBRAL BLOOD-FLOW IN ACUTE ARTERIAL-HYPERTENSION [J].
BILL, A ;
LINDER, J .
ACTA PHYSIOLOGICA SCANDINAVICA, 1976, 96 (01) :114-121
[6]   M2 MUSCARINIC RECEPTORS ON THE IRIS SPHINCTER MUSCLE DIFFER FROM THOSE ON IRIS NORADRENERGIC NERVES [J].
BOGNAR, IT ;
BAUMANN, B ;
DAMMANN, F ;
KNOLL, B ;
MEINCKE, M ;
PALLAS, S ;
FUDER, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 163 (2-3) :263-274
[7]   ANTAGONIST DISCRIMINATION BETWEEN GANGLIONIC AND ILEAL MUSCARINIC RECEPTORS [J].
BROWN, DA ;
FORWARD, A ;
MARSH, S .
BRITISH JOURNAL OF PHARMACOLOGY, 1980, 71 (02) :362-364
[8]   INHIBITORY EFFECT OF GALLAMINE ON MUSCARINIC RECEPTORS [J].
CLARK, AL ;
MITCHELSON, F .
BRITISH JOURNAL OF PHARMACOLOGY, 1976, 58 (03) :323-331
[9]  
DEIGHTON NM, 1990, N-S ARCH PHARMACOL, V341, P14
[10]  
DOODS HN, 1987, J PHARMACOL EXP THER, V242, P257